Ajooni Biotech Stock Price Analysis and Quick Research Report. Is Ajooni Biotech an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Ajooni Biotech. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Ajooni Biotech has a PE ratio of 26.6541529798217 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Ajooni Biotech has ROA of 4.0906% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Ajooni Biotech has a Current ratio of 10.7382.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Ajooni Biotech has a ROE of 5.1227%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Ajooni Biotech has a Debt to Equity ratio of 0.0508 which means that the company has low proportion of debt in its capital.

• Sales growth: Ajooni Biotech has reported revenue growth of 7.5541% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Ajooni Biotech for the current financial year is 2.78838064472644%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Ajooni Biotech is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Ajooni Biotech is Rs 0.2131. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Ajooni Biotech in Ticker for free. Also, one can get the intrinsic value of Ajooni Biotech by using Valuation Calculators, which are available with a Finology ONE subscription. 

Ajooni Biotech FAQs

Q1. What is Ajooni Biotech share price today?
Ans: The current share price of Ajooni Biotech is Rs 5.68.

Q2. What is the market capitalisation of Ajooni Biotech?
Ans: Ajooni Biotech has a market capitalisation of Rs 97.834363664 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Ajooni Biotech?
Ans: The PE ratio of Ajooni Biotech is 26.6541529798217 and the P/B ratio of Ajooni Biotech is 1.10098856367513, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Ajooni Biotech share?
Ans: The 52-week high share price of Ajooni Biotech is Rs 9.64, and the 52-week low share price of Ajooni Biotech is Rs 5.01.

Q5. Does Ajooni Biotech pay dividends?
Ans: Currently, Ajooni Biotech does not pay dividends. Dividend yield of Ajooni Biotech is around 0%.

Q6. What are the face value and book value of Ajooni Biotech shares?
Ans: The face value of Ajooni Biotech shares is Rs 2, while the book value per share of Ajooni Biotech is around Rs 5.159. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Ajooni Biotech?
Ans: Ajooni Biotech has a total debt of Rs 2.1677 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Ajooni Biotech?
Ans: The ROE of Ajooni Biotech is 5.1227% and ROCE of Ajooni Biotech is 7.7473%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Ajooni Biotech a good buy for the long term?
Ans: The Ajooni Biotech long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Ajooni Biotech undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Ajooni Biotech appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Ajooni Biotech’s financials?
Ans: You can review Ajooni Biotech’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.